How does modern medicine (allopathy) work?

In India, the medicine you get from an MBBS doctor, a pharmacy or a government hospital is often called allopathy. The word was coined around 1810 by Samuel Hahnemann, the German doctor who founded homeopathy, as a label for the medicine he disagreed with. It means "other suffering". Doctors today rarely use it about themselves: they call it modern medicine or biomedicine.

Modern medicine is not one tradition or one book. It is a way of working that rests on four foundations of science: anatomy (what the body is made of), physiology (how it works), germ theory (many diseases are caused by particular microbes) and pharmacology (how medicines act on specific targets). Disease is explained as something going wrong in that machinery, called pathophysiology.

What holds it together is the fair test. Any treatment, old or new, is kept only if careful trials show it helps more than it harms. When the evidence changes, the practice is meant to change too. This is evidence-based medicine, and it is the idea the rest of this box explores.

In India, doctors study the MBBS: four and a half years plus a one-year internship, after the NEET exam. Since 2020 the National Medical Commission regulates them. The public system is a ladder: a sub-centre for about 5,000 people, a primary health centre with a doctor for about 30,000, a community health centre with specialists, then district hospitals and medical colleges such as AIIMS. India also officially recognises Ayurveda, Yoga and Naturopathy, Unani, Siddha, Sowa-Rigpa and Homoeopathy, under the Ministry of AYUSH (2014); see AyurvedaClear, UnaniClear, SiddhaClear, NaturopathyClear and HomeopathyClear. Many families use more than one system.

Diagnosis starts with talking. The history (what you feel, since when, where you have been) gives most of the clues. Then the examination: temperature, pulse, blood pressure, listening to the chest with a stethoscope. Only then come tests: blood counts, urine tests, and imaging that sees inside you without cutting (see XrayClear, CTScanClear and MRIClear).

A doctor keeps a list of possible causes, the differential diagnosis, and every clue makes some more likely and some less. It is like detective work with numbers: this is Bayes' rule. In a Mumbai monsoon, a fever could be a virus, dengue, malaria, typhoid or leptospirosis; aches, a rash, low platelets and then a specific test narrow it down.

Tests are not perfect. Sensitivity is how often a test catches the disease when it is there; specificity is how often it says "no" when it isn't. Here is the surprise: if a disease is rare, even a very good test gives mostly false positives. Screen 1,000 people for something only 2 of them have, and a test that is 98% specific still flags about 20 healthy people. That is why a positive screening test is always confirmed with a different test before anyone is told they have a serious disease. India's HIV testing does exactly this.

Computers now help read X-rays and eye scans (see NeuralNetClear), but the same maths applies to them.

Most medicines work by fitting a target in your body, like a key in a lock. The targets are usually receptors (proteins on cells that receive signals) or enzymes (proteins that do chemical jobs). A drug that fits and turns the lock is an agonist, like salbutamol opening the airways in asthma. One that fits but jams the lock is an antagonist, like naloxone blocking an opioid overdose. Aspirin works by jamming an enzyme (COX) that makes pain and swelling signals.

More drug fills more locks, but the effect levels off once most are full: the dose-response curve is an S-shape. Push the dose higher and you reach other curves: side effects. The gap between the dose that helps and the dose that harms is the therapeutic window. Some medicines have a wide one; some, like digoxin, lithium or warfarin, have a narrow one, so doctors check blood levels.

A tablet then goes on a journey called ADME: absorption from the gut into the blood, distribution round the body, metabolism (mostly by the liver, see LiverClear) and excretion (mostly by the kidneys, see KidneyClear). The half-life is the time for the level in the blood to halve. It decides how often you take a medicine: short half-life, several times a day; long, once a day. After about 4 to 5 half-lives of regular doses, the level settles into a steady up-and-down inside the window.

That is why a doctor sets the dose and timing, and why doubling up after a missed dose can be risky. This box explains ideas only; follow your doctor and the label.

People often get better on their own, and they often feel better just because they were treated and cared for. So "I took it and got well" can't tell us whether a medicine works. The fair test can. It is the heart of modern medicine, and any treatment from any tradition can be put through it.

1. Compare. One group gets the treatment, a control group gets a dummy (a placebo) or the best existing treatment. 2. Randomise. A coin toss, not the doctor, decides who goes where, so the healthier-looking patients don't all end up in one group. 3. Blind. Neither patients nor assessors know who got what, so hope and expectation lift both groups equally. 4. Count enough people, and decide in advance what counts as success.

Even a fair trial is a sample, so chance moves its result around. The 95% confidence interval shows the range the true effect probably lies in. A p-value below 0.05 means a result this big would be rare if the treatment did nothing; but when a treatment truly does nothing, about 1 trial in 20 still crosses that line by luck. That is why one trial is never the last word.

So trials are combined: a systematic review finds every fair trial on a question, and a meta-analysis pools them. The Cochrane Collaboration (1993) does this worldwide, with a network in India based at CMC Vellore. But reviews can only pool what gets published: if trials with dull results stay in drawers, the pooled answer looks too good. That is publication bias, and it is why India requires every trial to be registered in advance on CTRI.

A new drug climbs phases: I (safety, in a few healthy volunteers), II (does it seem to work?), III (large randomised trials), then approval by India's CDSCO under the Drugs Controller General, and phase IV, watching for rare side effects through the Pharmacovigilance Programme of India. Only about 8 in 100 drugs that start phase I are approved. AyurvedaClear, HomeopathyClear, UnaniClear, SiddhaClear and NaturopathyClear all point here, because the same test applies to every system.

In 1951 a baby born in India could expect to live about 32 years. Today it is about 70. Most of that gain came from a handful of simple, well-tested ideas, and clean water, better food and more schooling, working together.

Vaccines (see ImmuneClear) wiped smallpox off the planet in 1980, India's last case being in 1975, and India was certified polio-free in 2014. Antibiotics, starting with penicillin in 1928, made killers like pneumonia and blood poisoning curable. Anaesthesia (1846) made surgery painless, and clean hands and instruments made it survivable. Insulin (1922) turned type 1 diabetes from a death sentence into a condition people live with.

One of the biggest wins is almost free. In 1971, in crowded refugee camps at Bangaon during the Bangladesh war, Dr Dilip Mahalanabis ran out of drips and gave cholera patients oral rehydration solution (ORS): water with the right amounts of salt and sugar. Deaths fell to about 1 in 30, where about 1 in 3 had been expected. ORS has since saved tens of millions of children.

Modern medicine also borrows from tradition, once the idea passes the fair test. Aspirin came from willow bark. Artemisinin, today's front-line malaria drug, came from a Chinese herbal text and won Tu Youyou the 2015 Nobel Prize. Reserpine, one of the first blood-pressure drugs, came from sarpagandha (Rauvolfia serpentina), long used in Ayurveda and studied by Indian doctors from 1931 (see AyurvedaClear). The source doesn't matter; the test does.

Modern medicine is powerful, and that power cuts both ways. Being honest about its limits is part of being evidence-based.

Side effects. Every medicine that does something can also do harm. In one large study, reactions to medicines caused about 1 in 15 hospital admissions. India's Pharmacovigilance Programme (PvPI) collects reports so rare problems are spotted; doctors, pharmacists and patients can all report.

Antibiotic resistance. Each unneeded course of antibiotics, for a cold, a viral fever or loose motions, kills the easy bacteria and leaves the tough ones to multiply (see ImmuneClear). Resistant infections killed about 1.27 million people worldwide in 2019. India, the world's largest user of antibiotics, now sells them only on prescription (the red line on the pack). Never self-medicate with antibiotics, don't share them, and take them exactly as the doctor says.

Too many medicines. Five or more at once (polypharmacy) is common in older people, and every extra one adds possible clashes. Overtreatment, tests and drugs that don't help, is a real problem too.

Cost, time and money. Indian families still pay over 40% of health costs from their own pockets, though Ayushman Bharat PM-JAY now covers hospital care up to ₹5 lakh a family a year for poorer families and everyone over 70, and Jan Aushadhi stores sell cheap generics. A typical Indian clinic visit lasts about 2 minutes. And drug companies fund many trials; industry-funded studies report favourable results more often, which is why registration and independent reviews matter.

Integrative care. Many Indian families use modern medicine alongside Ayurveda, Unani, Siddha, yoga or homeopathy. The fair debate is about evidence and safety: some practices, like yoga for back pain, have trial support; some remedies interact with medicines or have been found to contain heavy metals; and delaying proven treatment for serious illness is dangerous. Tell every doctor everything you take.

See a qualified doctor for any illness, and never start, stop or change a prescribed medicine on your own.